Asosiy kontentga oʻtish
Sharh maqola

The role of miRNA-128 in the development and progression of gastrointestinal and urogenital cancer

Ghaidaa Raheem Lateef Al‐AwsiDepartment of Radiological Techniques, Al-Mustaqbal University College, Babylon, IraqSaade Abdalkareem JasimDepartment of Medical Laboratory Techniques,Al-maarif University College, Al-Anbar-Ramadi, IraqYasser Fakri MustafaDepartment of Pharmaceutical Chemistry,College of Pharmacy,University of Mosul, Mosul, 41001, IraqFiras Rahi AlhachamiDepartment of Radiology,College of Health & Medical Technololgy,Al-Ayen University, Thi-Qar, IraqShukhrat ZiyadullaevNo. 1 Department of Internal Diseases, Vice-rector for Scientific Affairs & Innovations,Samarkand State Medical University, Amir Temur Street 18, Samarkand, UzbekistanMahmoud KandeelDepartment of Pharmacology,Faculty of Veterinary Medicine,Kafrelshikh University, Kafrelshikh, 33516, EgyptRoua AbulkassimAl-Manara College for Medical Science, Misan, IraqR. SivaramanDepartment of Mathematics,Dwaraka Doss Goverdhan Doss Vaishnav College, Arumbakkam,University of Madras, Chennai, IndiaNoora M. HameedAnesthesia Techniques,Al-Nisour University College, IraqRosario Mireya Romero‐ParraUniversidad Continental, Lima, PerúSajad KarampoorGastrointestinal & Liver Diseases Research Center,Iran University of Medical Sciences, Tehran, IranRasoul MirzaeiDepartment of Medical Biotechnology,Venom & Biotherapeutics Molecules Lab,Biotechnology Research Center,Pasteur Institute of Iran, Tehran, Iran
Future Oncologyjournal2022en

Ochiq kirish: yoʻq

ABI

Annotatsiya

Increasing data have shown the significance of various miRNAs in malignancy. In this regard, parallel to its biological role in normal tissues, miRNA-128 (miR-128) has been found to play an essential immunomodulatory function in the process of cancer initiation and development. The occurrence of the aberrant expression of miR-128 in tumors and the unique properties of miRNAs raise the prospect of their use as biomarkers and the next generation of molecular anticancer therapies. The function of miR-128 in malignancies such as breast, prostate, colorectal, gastric, pancreatic, esophageal, cervical, ovarian and bladder cancers and hepatocellular carcinoma is discussed in this review. Finally, the effect of exosomal miR-128 on cancer resistance to therapeutics and cancer immunotherapy in certain malignancies is highlighted.

Hali tarjima qilinmagan

Mavzular

Identifikatorlar

Iqtiboslar va manbalar